Organic compounds -- part of the class 532-570 series – Organic compounds – Nitrogen attached directly or indirectly to the purine ring...
Reexamination Certificate
2011-07-12
2011-07-12
Balasubramanian, Venkataraman (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Nitrogen attached directly or indirectly to the purine ring...
C514S275000
Reexamination Certificate
active
07977481
ABSTRACT:
The present invention provides novel pyrimidinyl-thiophene kinase modulators and methods of using the novel pyrimidinyl-thiophene kinase modulators to treat diseases mediated by kinase activity.
REFERENCES:
patent: 5162328 (1992-11-01), Paul et al.
patent: 5643734 (1997-07-01), Henderson
patent: 6589950 (2003-07-01), Collingwood et al.
patent: 6642227 (2003-11-01), Cao et al.
patent: 2003/0220330 (2003-11-01), Yoshitaka et al.
patent: 0233461 (1987-08-01), None
patent: 0453731 (1991-10-01), None
patent: WO 97/19065 (1997-05-01), None
patent: WO 02/083667 (2002-10-01), None
patent: WO 03/087816 (2003-10-01), None
patent: WO 2005/095386 (2005-10-01), None
patent: WO 2006/044457 (2006-04-01), None
patent: 2007/018941 (2007-02-01), None
Moretti, L. et al., “Tyrosine Kinase Drug Discovery: What Can Be Learned From Solved Crystal Structures?”, Issue Italian-Swiss Medicinal Chemistry Meeting, ARKIVOC 2006 (viii), pp. 38-49.
Noble, Martin E.M. et al., “Protein Kinase Inhibitors: Insights Into Drug Design From Structure,” Science, vol. 303, Mar. 19, 2004, pp. 1800-1805.
Cecil Textbook of Medicine, edited by Bennet, J.C., and Plum, F., 20thedition, vol. 1, 1004-1010, 1996.
Cohen et al., Current Opinion in Chemical Biology, 3, 459-465, 1999.
Dermer et al., Bio/Technology, 1994, 12:320.
Freshney et al., Culture of Animal Cells, A Manual of Basic Technique, Alan R. Liss, Inc., 1983, New York, p. 4.
Golub et al., Science, 286, 531-537, 1999.
Powell et al., British Journal of Dermatology, 141: 802-812, 1999.
Mass, R.D., Int. J. Radiation Oncology Bio. Phys. vol. 58(3): 932-940, 2004.
Bursavich, Matthew G. et al., “Expedient Parallel Synthesis of 2-Amino-4-heteroarylpyrimidines,” Organic letters (2005) 7(19):41 13-4116.
Zimmermann, Jürg et al., “Phenylamino-Pyrimidine (PAP)—Derivatives: A New Class of Potent and Highly Selective PDGF-Receptor Autophosphorylation Inhibitors,” Bioorganic & Medicinal Chemistry Letters (1996) 6(11): 1221-1226.
Zimmermann, Jürg et al., “Phenylamino-Pyrimidine (PAP)—Derivatives: A New Class of Potent and Selective Inhibitors of Protein Kinase C (PKC),,” Arch. Pharm. Pharm. Med. Chem. (1996) 329(7):371-376.
Paul, Rolf et al., “Preparation of SubstitutedN-Phenyl-4-aryl-2-pyrimidinamines as Mediator Release Inhibitors,” J. Med. Chem. (1993) 36(19):2716-2725.
Harrington, “VX-680, a potent and selective small-molecule inhibitor of the Auror kinases, suppresses tumor growth in vivo,” Nature Medicine Advance Online Publication: 1-6 (2004).
Feldman et al., “Novel Small Molecule Inhibitors of 3-Phosphoinositide-Dependent Kinase—1(PDK1),” JBC Papers in Press: 1-24, Published Mar. 16, 2005 Manuscript M501367200.
Berge et al., Pharmaceutical Salts, J. Pharma. Sci. 66:1-19 (1977).
Yin et al., “Pd-Catalyzed N-Arylation of Heteroarylamines,” Org. Ltrs. 4(20):3481-3484 (2002).
Thompson et al., “DbClustal: rapid and reliable global multiple alignments of protein sequences detected by database searches,” Nucl. Acids Res. 28:2919-2926 (2000).
Gouet et al., “ESPript: analysis of multiple sequence Alignments in Postscript,” Bioinformatics 15:305-308 (1999).
Altschul et al., “Gapped Blast and PSI-Blast: a new generation of protein database search programs,” Nucl. Acids Res. 24:3389-3402 (1997).
Blaney, J.M. and Dixon, J.S., “A good ligand is hard to find: Automated docking methods,” Perspectives in Drug Discovery and Design 1:301-319.
Brooks et al., “CHARMM: A program for macromolecular energy, minimization, and dynamics calculations,” J. Comp. Chem. 4:187-217 (1983).
Weiner et al., “A new force field for molecular mechanical simulation of nucleic acids and proteins,” J. Am. Chem. Soc. 106;765-784 (1984).
Kuntz et al., A Geometric Approach to Macromolecular-Ligand Interactions, J. Mol. Biol. 161:269-288.
Jones et al., “Molecular Recognition of Receptor Sites Using a Genetic Algorithm with a Description of Desolvation,” J. Mol. Biol. 245-43-53 (1995).
Rarey, M. et al., “A Fast Flexible Docking Method Using an Incremental Construction Algorithm,” J. Mol. Biol. 261 :470-489 (1996).
Travis, J., “Proteins and Organic Solvents make an Eye-Opening Mix,” Science 262:1374 (1993).
Meng et al., “Automated Docking with Grid-Based Energy Evaluation,” J. Comp. Chem. 13:505-524 (992).
Charifson, P.S. et al., “Consensus Scoring: A Method for Obtaining Improved Hit Rates from Docking Databases of Three-Dimensional Structures into Proteins,” J. Med. Chem. 41:5100-5109 (1999).
Balakin, K.V. et al., “Rational Design Approaches to Chemical Libraries for Hit Identification,” Curr. Drug Del. Technol. 3:49-65 (2006).
Congreve, M. et al., “Keynote Review: Structural biology and drug discovery,” DDT 10(13):895-907 (2005).
Langer, T. and Krovat, E.M., “Chemical feature-based pharmacophones and virtual library screening for discovery of new leads,” Curr. Op. Drug Discovery Develop. 6(3):370-376(2003).
Fabbro et al., Pharmacology & Therapeutics 93, 79-98, 2002.
Arnold William D.
Chen Chixu
Gradl Stefan N.
Hopkins Stephanie
Steensma Ruo W.
Balasubramanian Venkataraman
Ginah Francis O.
SGX Pharmaceuticals Inc.
LandOfFree
Pyrimidinyl-thiophene kinase modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrimidinyl-thiophene kinase modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidinyl-thiophene kinase modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2621888